Enantioselective total synthesis of (-)-dibromophakellstatin

Synlett

Volumn , Issue 17, 2007, Pages 2756-2758

  Zöllinger, Michael ^a   Mayer, Peter ^a   Lindel, Thomas ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Hydroxyproline; Imidazolidinone; Marine natural products; N oxycarbamates; Pyrrole imidazole alkaloids

Indexed keywords

ANTINEOPLASTIC AGENT; DIBROMOPHAKELLSTATIN; DIPYRROLOPYRAZINONE; IMIDAZOLIDINONE; IMIDAZOLINE DERIVATIVE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANNULATION REACTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; PHAKELLIA MAURITIANA; SPONGE (PORIFERA);

EID: 35648950535     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986664     Document Type: Article

References (25)

1. Al-Mourabit, A.; Potier, P. Eur. J. Org. Chem. 2001, 237.
2. (a) Hoffmann, H.; Lindel, T. Synthesis 2003, 1753.
3. (b) Jacquot, D. E. N.; Lindel, T. Curr. Org Chem. 2005, 9, 1551.
4. Pettit, G. R.; McNulty, J.; Herald, D. L.; Doubek, D. L.; Chapuis, J. C.; Schmidt, J. M.; Tackett, L. P.; Boyd, M. R. J. Nat. Prod 1997, 60, 180.
5. 50 of 0.7 μM against the glioblastoma cancer cell line CNXF 498NL, while (+)-1 was inactive. See: Zöllinger, M.; Kelter, G.; Fiebig, H.-H.; Lindel, T. Bioorg. Med. Chem. Lett. 2007, 17, 346.
6. Poullennec, K. G.; Romo, D. J. Am. Chem. Soc. 2003, 125, 6344.
7. Jacquot, D. E. N.; Zöllinger, M.; Lindel, T. Angew. Chem. Int. Ed. 2005, 44, 2295.
8. Wiese, K. J.; Yakushijin, K.; Horne, D. A. Tetrahedron Lett. 2002, 43, 5135.
9. Feldman, K. S.; Skoumbourdis, A. P. Org. Lett. 2005, 7, 929.
10. Chung, R.; Yu, E.; Incarvito, C. D.; Austin, D. J. Org. Lett. 2004, 6, 3881.
11. Lu, J.; Tan, X.; Chen, C. J. Am. Chem. Soc. 2007, 129, 7768.
12. Zöllinger, M.; Mayer, P.; Lindel, T. J. Org. Chem. 2006, 71, 9431.
13. Compound 4 can be obtained by alkaline hydrolysis of the corresponding trichloromethylketone. See: Bailey, D. M.; Johnson, R. E. J. Med. Chem. 1973, 16, 1300.
14. CCDC-623847 (12) and CCDC-623846 (15) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB21EZ, UK; fax: +44 (1223)336033; or deposit@ccdc.cam.ac.uk].
15. (a) Lwowski, W.; Maricich, T. J. J. Am. Chem. Soc. 1963, 85, 1200.
16. (b) Lwowski, W.; Maricich, T. J. J. Am. Chem. Soc. 1965, 87, 3630.
17. Fioravanti, S.; Loreto, M. A.; Pellacani, L.; Tardella, P. A. J. Org. Chem. 1985, 50, 5365.
18. (a) Burgess, E. M.; Penton, H. R.; Taylor, E. A. J. Org. Chem. 1973, 38, 26.
19. (b) Burgess, E. M.; Penton, H. R.; Taylor, E. A. J. Am. Chem. Soc. 1970, 92, 5224.
20. Appel, R. Angew. Chem., Int. Ed. Engl. 1975, 14, 801.
21. 7S + H]: 553.0393; found: 553.0375.
22. 2 has rarely been reported: (a) Inanaga, J.; Ishikawa, M.; Yamaguchi, M. Chem. Lett. 1987, 1485.
23. (b) Ogawa, A.; Nanke, T.; Takami, N.; Sumino, Y.; Ryu, I.; Sonoda, N. Chem. Lett. 1994, 379.
24. Compound 17 had also been obtained as the (+)-enantiomer by Romo (ref. 5) and as the racemate by Austin (ref. 9).
25. +]: 388.9249; found: 388.9255.